Related Experiment Video

Updated: Aug 16, 2026

Multiplexed Fluorescent Immunohistochemical Staining of Four Endometrial Immune Cell Types in Recurrent Miscarriage
05:16

Multiplexed Fluorescent Immunohistochemical Staining of Four Endometrial Immune Cell Types in Recurrent Miscarriage

Published on: August 4, 2021

Systemic lupus erythematosus, repeated abortions, and thrombocytopenia

M H Pritchard, J D Jessop, P M Trenchard

    Annals of the Rheumatic Diseases
    |October 1, 1978
    PubMed

    Abstract:

    A case is described of severe thrombocytopenia in a pregnant patient with mild SLE. Three previous pregnancies had ended in abortion. Attempts to reverse the thrombocytopenia with steroids, plasmapheresis, and splenectomy failed, the platelet count returning to normal immediately after the death of the fetus at 20 weeks gestation.

    More Related Videos

    Platform for Quantitative Detection of Endometrial Immune Cells Based on Immunohistochemistry and Digital Image Analysis
    07:46

    Platform for Quantitative Detection of Endometrial Immune Cells Based on Immunohistochemistry and Digital Image Analysis

    Published on: October 13, 2023

    Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes
    04:08

    Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes

    Published on: June 27, 2025

    Related Experiment Videos

    Last Updated: Aug 16, 2026

    Multiplexed Fluorescent Immunohistochemical Staining of Four Endometrial Immune Cell Types in Recurrent Miscarriage
    05:16

    Multiplexed Fluorescent Immunohistochemical Staining of Four Endometrial Immune Cell Types in Recurrent Miscarriage

    Published on: August 4, 2021

    Platform for Quantitative Detection of Endometrial Immune Cells Based on Immunohistochemistry and Digital Image Analysis
    07:46

    Platform for Quantitative Detection of Endometrial Immune Cells Based on Immunohistochemistry and Digital Image Analysis

    Published on: October 13, 2023

    Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes
    04:08

    Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes

    Published on: June 27, 2025

    Related Concept Videos

    Teratogenicity01:07

    Teratogenicity

    The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...

    Articles linked to this work by shared authors, journal, and citation graph.

    The in vitro anti-denaturation effects induced by natural products and non-steroidal compounds in heat treated (immunogenic) bovine serum albumin is proposed as a screening assay for the detection of anti-inflammatory compounds, without the use of animals, in the early stages of the drug discovery process.

    The West Indian medical journal·2009

    Immunological evidence supporting the use of extracts from Boehmeria jamaicensis Urb for treating the common cold and sinus infections.

    The West Indian medical journal·2008

    Chronic compartment syndrome, an important cause of work-related upper limb disorder.

    Rheumatology (Oxford, England)·2005

    What factors influence functional ability in patients with rheumatoid arthritis. Do they alter over time?

    Rheumatology (Oxford, England)·2005

    Low-threshold L-type calcium channels in rat dopamine neurons.

    Journal of neurophysiology·2003

    Deregulated expression of promyelocytic leukemia zinc finger protein in B-cell chronic lymphocytic leukemias does not affect cyclin A expression.

    The hematology journal : the official journal of the European Haematology Association·2002

    Improvement in neuropsychological function with memantine treatment among patients with systemic lupus erythematosus: a phase 2 randomised placebo-controlled clinical trial.

    Annals of the rheumatic diseases·2026

    Interferon-stimulated gene signature predicts clinical response to low-dose IL-2 in immune-mediated inflammatory diseases.

    Annals of the rheumatic diseases·2026

    Low-dose blinatumomab in multidrug-resistant rheumatoid arthritis-a case series.

    Annals of the rheumatic diseases·2026

    Spatially distinct macrophage subsets drive myofibroblast heterogeneity and maladaptive fibrosis in lupus nephritis.

    Annals of the rheumatic diseases·2026

    Efficacy and safety of filgotinib in patients with active radiographic and nonradiographic axial spondyloarthritis: results from OLINGUITO, a phase 3 trial consisting of 2 randomised, placebo-controlled, double-blind, parallel-group studies.

    Annals of the rheumatic diseases·2026

    High-sensitivity flow cytometry in rheumatoid arthritis shows that early B-cell subset depletion is linked to 5-year rituximab response, while failure to deplete B cells occurs early in subsequent poly-refractory disease.

    Annals of the rheumatic diseases·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us